Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

7.13
Delayed Data
As of 3:59pm ET
 +0.09 / +1.28%
Today’s Change
3.07
Today|||52-Week Range
8.22
+15.93%
Year-to-Date

Today’s Trading

Previous close7.04
Today’s open7.07
Day’s range7.01 - 7.24
Volume450,931
Average volume (3 months)620,949
Market cap$427.7M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-28.00%
Earnings growth (this year)+18.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+118.29%
P/E ratioNM
Price/Sales864.88
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc-0.04-0.27%
BSTCBiospecifics Technol...+0.73+1.61%
CASCCascadian Therapeuti...+0.06+3.77%
NVIVInVivo Therapeutics ...+0.03+0.45%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 22, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$382.0K
Annual profit (last year)-$91.9M
Net profit margin-24,068.29%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts

Search for Jobs